These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11350856

  • 1. Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy.
    Goossens PH, Verburg RJ, Breedveld FC.
    Ann Rheum Dis; 2001 Jun; 60(6):637. PubMed ID: 11350856
    [No Abstract] [Full Text] [Related]

  • 2. Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.
    Licata G, Pinto A, Tuttolomondo A, Banco A, Ciccia F, Ferrante A, Triolo G.
    Ann Rheum Dis; 2003 Mar; 62(3):280-1. PubMed ID: 12594127
    [No Abstract] [Full Text] [Related]

  • 3. Successful treatment of genital ulcers with infliximab in Behcet's disease.
    Haugeberg G, Velken M, Johnsen V.
    Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
    [No Abstract] [Full Text] [Related]

  • 4. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M, Cinal A, Topcu N, Demirok A.
    Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
    [No Abstract] [Full Text] [Related]

  • 5. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P, D'Angelo S, Angela P, Coniglio G, Olivieri I.
    Clin Exp Rheumatol; 2010 May; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract] [Full Text] [Related]

  • 6. Behçet's disease: a new target for anti-tumour necrosis factor treatment.
    Sfikakis PP.
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii51-3. PubMed ID: 12379622
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of long-standing neuro-Behçet's disease with infliximab.
    Sarwar H, McGrath H, Espinoza LR.
    J Rheumatol; 2005 Jan; 32(1):181-3. PubMed ID: 15630746
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
    Olivieri I, D' Angelo S, Padula A, Leccese P, Mennillo GA.
    Clin Exp Rheumatol; 2009 Jan; 27(2 Suppl 53):S112. PubMed ID: 19796550
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Remission of Behçet's syndrome with TNFalpha blocking treatment.
    Rozenbaum M, Rosner I, Portnoy E.
    Ann Rheum Dis; 2002 Mar; 61(3):283-4. PubMed ID: 11830448
    [No Abstract] [Full Text] [Related]

  • 12. One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs.
    Giardina A, Ferrante A, Ciccia F, Vadalà M, Giardina E, Triolo G.
    Rheumatol Int; 2011 Jan; 31(1):33-7. PubMed ID: 19859715
    [Abstract] [Full Text] [Related]

  • 13. Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
    Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN.
    Lancet; 2001 Jul 28; 358(9278):295-6. PubMed ID: 11498218
    [Abstract] [Full Text] [Related]

  • 14. Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease.
    Triolo G, Vadalà M, Accardo-Palumbo A, Ferrante A, Ciccia F, Giardina E, Citarrella P, Lodato G, Licata G.
    Ann Rheum Dis; 2002 Jun 28; 61(6):560-1. PubMed ID: 12006336
    [No Abstract] [Full Text] [Related]

  • 15. Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
    Fujikawa K, Aratake K, Kawakami A, Aramaki T, Iwanaga N, Izumi Y, Arima K, Kamachi M, Tamai M, Huang M, Nakamura H, Nishiura Y, Origuchi T, Ida H, Eguchi K.
    Ann Rheum Dis; 2007 Jan 28; 66(1):136-7. PubMed ID: 17178762
    [No Abstract] [Full Text] [Related]

  • 16. Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.
    Kram MT, May LD, Goodman S, Molinas S.
    Dis Colon Rectum; 2003 Jan 28; 46(1):118-21. PubMed ID: 12544532
    [Abstract] [Full Text] [Related]

  • 17. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B, Sablé-Fourtassou R, Bodaghi B, Huong DL, Cassoux N, Badelon I, Fain O, LeHoang P, Piette JC.
    Clin Exp Rheumatol; 2004 Jan 28; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [Abstract] [Full Text] [Related]

  • 18. Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.
    Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H.
    Rheumatology (Oxford); 2007 May 28; 46(5):736-41. PubMed ID: 17403712
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.